CIRB Studies

Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.

To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.

Displaying 651 - 660 of 730
Study Number Lead Group Study Title CIRB Study Status
ACCL1034 COG Impact of Cleansing with Chlorhexidine Gluconate (CHG) on Reducing Central Line Associated Bloodstream Infection (CLABSI) and Acquisition of Multi-drug Resistant Organisms (MDRO) in Children with Cancer or Those Receiving Allogeneic Hematopoietic Cell Transplantation (HCT): A Limited Phase III Study Pediatric CIRB Available to Open
APEC1621-MASTER COG NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) Study Pediatric CIRB Available to Open
ADVL1622 COG Phase 2 Trial of XL184 (Cabozantinib); an Oral Small-Molecule Inhibitor of Multiple Kinases; in Children and Young Adults with Refractory Sarcomas; Wilms Tumor; and Other Rare Tumors Pediatric CIRB Available to Open
ACCL05C1 COG A Group-Wide; Prospective Study of Ototoxicity Assessment in Children Receiving Cisplatin Chemotherapy Pediatric CIRB Completed
ARST0531 COG Randomized Study of Vincristine; Dactinomycin and Cyclophosphamide (VAC) versus VAC Alternating with Vincristine and Irinotecan (VI) for Patients with Intermediate-Risk Rhabdomyosarcoma (RMS): A Groupwide Phase III Study Pediatric CIRB Available to Open
AHOD1221 COG A Phase 1/2 Study of Brentuximab Vedotin (SGN35; IND# 117117) in Combination with Gemcitabine for Pediatric and Young Adult Patients with Relapsed or Refractory Hodgkin Lymphoma Pediatric CIRB Available to Open
NWU2014-04-01 CLO-Northwestern University Statin Therapy to Reduce the Risk of Recurrent Pancreatitis Cancer Prevention and Control CIRB Available to Open
MAY2016-07-01 CLO-Mayo Clinic Phase II Trial of Weekly Erlotinib Dosing to Reduce Duodenal Polyp Burden Associated with Familial Adenomatous Polyposis Cancer Prevention and Control CIRB Available to Open
NRG-CC003 NRG Randomized Phase II/III Trial of Prophylactic Cranial Irradiation with Or without Hippocampal Avoidance for Small Cell Lung Cancer Cancer Prevention and Control CIRB Available to Open
MDA2017-09-03 CLO-MD Anderson Pilot Study of Denosumab in BRCA1/2 Mutation Carriers scheduled for Risk-reducing Salpingooophorectomy Cancer Prevention and Control CIRB Available to Open
Displaying 651 - 660 of 730